You are here

Biographical notes for "Community as Treatment: The Opioid Epidemic and the Therapeutic Community Model"

See all details on this Nov. 9 event here.

Jonathan Avery, MD (Director of Addiction Psychiatry; Assistant Professor of Clinical Psychiatry, Weill Cornell Medical College; New York-Presbyterian Hospital)

Dr. Avery is currently the Director of Addiction Psychiatry and an Assistant Attending Psychiatrist at New York-Presbyterian Hospital. He is an Assistant Professor of Clinical Psychiatry and the Assistant Dean of Student Affairs at Weill Cornell Medical College. Dr. Avery is a graduate of the New York University School of Medicine. He completed his residency training at New York-Presbyterian Hospital/Payne Whitney Clinic. During residency, he was selected as a Group for the Advancement of Psychiatry Fellow and won several awards for his clinical and academic work. He was co-chief resident in his final year of training. Prior to employment on the Cornell faculty, Dr. Avery completed an addiction psychiatry fellowship at the New York University School of Medicine.
In addition to his clinical work, Dr. Avery teaches addiction psychiatry to the Weill Cornell medical students and residents of New York-Presbyterian Hospital. He has been published on a broad variety of topics in psychiatry, including papers on subjects ranging from clinician attitudes towards patients to how to use buprenorphine. He was on the editorial board for the DSM-5 Clinical Cases book, and is the editor of the book Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment. He has won numerous awards for his clinical and academic work, including the American Board of Psychiatry and Neurology Faculty Innovation in Education Award and the Outstanding Faculty Member Award from the New York County Psychiatric Society.

Daniele Bodini (Chairman, Friends of San Patrignano)

The founder of American Continental Properties Group (ACPG), Daniele Bodini served as the Ambassador of the Republic of San Marino to the United Nations from 2005 to 2016.
He is chairman of the American-Italian Cancer Foundation, chairman of the Foundation for Italian Art & Culture, and chairman of San Patrignano USA. He is a member of the boards of the Buffalo Bill Center of the West (Cody, Wyoming), the Council for the United States and Italy, and the Palazzo Strozzi Foundation USA.
Ambassador Bodini was born in Italy and received an MA in engineering from the University of Rome in 1968 and an MA in architecture in 1970. In 1972, he received an MBA from Columbia Business School.

Bruno Genetti (Explora - Research and statistical analysis, Padua)

Bruno Genetti (1965) is statistician and co-director of Explora – Centre of Research and Statistical Analysis (Padua). He gained his professional experience in social and health research; in the last twenty years he has focused on addictions at the regional and national level. From 2009 to 2014, he coordinated the statistical team of the Department of Anti-Drug Policies of the Presidency of the Council of Ministers (Italian Government). He coordinated the information flows from central, regional and local administrations for the annual report to the Parliament on the state of drug addiction in Italy, the National Report for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and for the World United Nations Drug Report (UNODC). He has directed and coordinated numerous multi-centre studies across the country, including the study on the evaluation of outcomes of outpatient treatment services. In the epidemiological field, he planned and directed several national surveys of the general and school population about the use of psychotropic substances. In 2017-2018 he planned and directed the first national gambling survey, promoted by the Istituto Superiore di Sanità (Ministry of Health), with face-to-face questionnaires to a sample of 12,000 residents in Italy.

Phaedon Kaloterakis, MWS (Assistant Director, KETHEA, Greece; Vice President, European Federation of Therapeutic Communities [EFTC])

Phaedon Kaloterakis is the Assistant Director of KETHEA, KETHEA being one of the largest drug treatment organizations in Europe.
Phaedon has been involved with the addiction field since 1980 and is a much sought after speaker worldwide at international conferences on addiction and has published many articles and scientific papers.
He lectures at various universities in Greece and abroad including the National School of Judges and the National Police Academy.
Phaedon also serves at various international boards such as, among others, the International Certification and Reciprocity Consortium (ICRC) and the Therapeutic Communities Journal’s International Editorial Advisory Group. He currently serves as Vice President of the European Federation of Therapeutic Communities (EFTC) and Chair of the International Relations and Liaison Committee and the Policies and Organizational Perspectives Committee of the World Federation of Therapeutic Communities (WFTC).
Phaedon represents KETHEA at the Economic and Social Council (ECOSOC) at the U.N. and is a scientific consultant of the United Nations Office on Drugs and Crime (UNODC).

Kristopher Kast, MD (Chief Psychiatry Resident, Weill Cornell Medical College, New York-Presbyterian Hospital)

Kristopher A. "Kris" Kast, M.D. is currently serving as Chief Resident for General Adult Psychiatry at the Payne Whitney Clinic of New York-Presbyterian Hospital | Weill Cornell Medicine. He received his bachelor’s degree summa cum laude from Notre Dame, then graduated from the Johns Hopkins University School of Medicine where he was elected to the Alpha Omega Alpha Honor Medical Society. He has received a 2017 AAAP Travel Award and Scholarship, as well as fellowship awards from the DeWitt Wallace Institute for the History of Psychiatry and the American Psychoanalytic Association.

Monika Kolodziej, PhD (Director of Psychological Services, Fernside, McLean Hospital; Instructor of Psychology, Harvard Medical School)

Monika Kolodziej, PhD, is the Director of Psychological Services at the McLean Fernside residential treatment program in the Alcohol and Drug Abuse Division at McLean Hospital, and Instructor in Psychology at the Department of Psychiatry at Harvard Medical School. Her clinical, research, and program evaluation activities focus on services for persons diagnosed with co-occurring substance use and other psychiatric and medical disorders. Dr. Kolodziej has worked on clinical trials to develop effective treatments for substance use and comorbid disorders, and has been part of federal and state-funded projects to implement: integrated medical and behavioral care for persons with chronic mental illness, comprehensive services for veterans with history of trauma, and substance abuse interventions for medically hospitalized patients. Having worked in medical, psychiatric, and substance addiction treatment settings, she is especially interested in implementing effective strategies to increase collaboration between patients, families, multi-disciplinary providers, and recovery advocates.

Gabriele Manella (University of Bologna - Ce.P.Ci.T. research center)

Gabriele Manella (1977) is Associate Professor at the University of Bologna, where he teaches Sociology of Territory. He is the Scientific Secretary of Ce.P.Ci.T. (a Bologna research center on urban and local problems). He was Visiting Research Scholar at the New York University (2007), the University of Chicago (2009), the Brown University (2010), the University of Denver (2011) and the Portland State University (2017). He works on drug addiction since 2004, and he participated to several studies promoted by the San Patrignano therapeutic community as well as some national studies on this topic. He is the co-author of the volume Il consumo di sostanze psicotrope e il giodo d’azzardo in Italia (2018).

John Mariani, MD (Director, Substance Treatment and Research Service [STARS]; Associate Professor of Clinical Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center)

Dr. John Mariani is an Associate Professor of Clinical Psychiatry at the College of Physicians and Surgeons of Columbia University and a Research Psychiatrist at the New York State Psychiatric Institute. After receiving his medical degree from the New York University School of Medicine and completing his psychiatry residency at the Beth Israel Medical Center in New York City, where he served as Chief Resident, Dr. Mariani began a two-year addiction psychiatry research fellowship at Columbia University. In 2005, he joined the faculty of the Division on Substance Abuse as a Research Psychiatrist. Under the mentorship of Dr. Frances Levin, he has remained active in clinical research and is the recipient of a K-23 Mentored Patient-Oriented Research Career Development Award from the National Institute on Drug Abuse. Currently, Dr. Mariani is the Director of Columbia University’s Substance Treatment and Research Service (STARS). His research has primarily focused on investigating novel pharmacotherapies for addictive disorders.

Letizia Moratti (Co-founder, San Patrignano Foundation)

Born on 26th November 1949, Letizia Brichetto Arnaboldi Moratti has three degrees: two in Political Sciences, one in Educational and Training Sciences. She is one of Europe's best-known businesswomen thanks to her 25 years of international activities in finance, insurance and risk management, communications services and the new media. In the course of her private business career, Letizia Moratti acquired the Nikols Group in 1994. Nikols then joined in an international alliance with the Sedgwick Group and she was Chairman of Nikols Sedgwick, Responsible for South Europe and Latin America and member of the Board of Sedgwick UK. As President and Managing Director of News Corp Europe, from November 1998 to September 1999, Letizia Moratti created the European expansion plan for this group, headed by Rupert Murdoch. During this time she was member of the board of News Corporation Ltd USA and of Britain's BSkyB television network.
Letizia Brichetto Arnaboldi Moratti founded and chairs E4Impact Foundation created to train a new generation of impact entrepreneurs in developing countries, especially in Africa. In 2016 she was appointed Chairman of Management Board of UBI Bank and she was elected member of the Board of ABI (Italian Banking Association). Since 2018 she is Board Member of Bracco Spa.